Presented in 2019 at the 14th Annual PDA Global Conference on Pharmaceutical Microbiology, Bethesda MD
PDA Bethesda 2019
Strategic Consulting, Inc. was pleased to have had a poster presentation at the 14th Annual PDA Conference on Pharmaceutical Microbiology. The poster presented the results of our work in studying and measuring the volume and market value of worldwide microbiological testing in the pharmaceutical sector.
Strategic Consulting, Inc. collected primary data on the number and types of tests conducted worldwide, using interviews and electronic surveys with key knowledgeable individuals at more than 300 pharmaceutical facilities in North America, Europe, Latin America and Asia (incl. India and China). The market at the end of 2018 was validated as consisting of a worldwide test volume of 415 million tests and a market value for test materials of $1.64 billion.
It is important to recognize that Strategic Consulting defines the worldwide pharma sector as including approximately 5,400 plants with 25 or more employees. Our research project focused only on these facilities and did not attempt to collect data from smaller facilities. These facilities were found to conduct an average of approx. 77,000 tests per year, with a very wide range in test volumes with smaller facilities that may collect “thousands” of tests per year to the largest pharma plants that collect more than 1 million tests per year.
Due to the crucial nature of this testing, and the steady growth of the pharmaceutical manufacturing sector, the growth of this market has continued steadily since we first started tracking this market in 1993. The worldwide Pharma Sector has shown steady growth in test volume from 105 million tests in 1993, 206 million tests in 2003, 348 million tests in 2014 to our estimated volume of 415 million tests in 2018. This growth is expected to continue at a slightly faster growth rate and reach 526 million tests in 2023.
The market value of Industrial Microbiology testing in the Pharma Sector has gained steadily from US$ 365 million in 1993, US$ 995 million in 2008, and now reaching over US$1.640 billion in 2018. With a slightly decreasing rate of market value growth expected, due to developing competition that will add to pricing pressure, the Pharma Sector is projected to reach an estimated US $2.1 billion in market value by 2023.